Artículos científicos

CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists’ perceptions
Fernando Moreno, Departamento de Oncología Médica, Hospital Universitario Clínico San Carlos, Madrid, Spain.
Vega Iranzo, Isabel Álvarez, Antonio Antón, José Ignacio Chacón, Joaquín Gavilá, Miguel Martín, Pedro Sánchez Rovira, Paula Gratal, Marta Julia Fernández González, Rafael López
Clinical and Translational Oncology – Marzo 2025

Recommendations for the management of cutaneous squamous cell carcinoma: a systematic multidisciplinary Delphi consensus approach
Eva Muñoz Couselo, Servicio de Oncología Médica, Hospital Universitario Vall d’Hebron e Instituto de Oncología Vall d’Hebron (VHIO), Barcelona, Spain.
Javier Cañueto, Vanessa Jerviz Guía, Ana María López López, Josep Oriol Bermejo Segú, Almudena García Castaño, Susana Puig Sardá, Onofre Sanmartín Jiménez, Ainara Soria Rivas, Paula Gratal, María Teresa Pardo, Álvaro Rogado, Alfonso Berrocal Jaime.
Clinical and Translational Oncology – Diciembre 2024

Improving quality of care by standardising patient data collection in electronic medical records in an oncology department in Spain
Guillermo Alonso-Jáudenes Curbera, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
Martín Igor Gómez-Randulfe Rodríguez, Beatriz Alonso de Castro, Sofía Silva Díaz, Iria Parajó Vázquez, Paula Gratal, Rafael López López, Rosario García Campelo.
BMJ Open Quality – Junio 2024

Criteria and indicators to evaluate quality of care in genitourinary tumour boards
Javier Puente, Servicio de Oncología Médica, Hospital Universitario Clínico San Carlos, Madrid, Spain.
Ferrán Algaba Arrea, Óscar Buisán Rueda, Daniel Castellano Gauna, Ignacio Durán, Juan José Fernández Ávila, Alfonso Gómez-Iturriaga, Mariano José Parada Blázquez, Daniel Pérez Fentes, Gemma Sancho Pardo, Juan Antonio Vallejo Casas, Paula Gratal, María Teresa Pardo, Vicente Guillem Porta.
Clinical and Translational Oncology – Febrero 2024

Indicators to evaluate quality of care in head and neck cancer in Spain
Virginia Arrazubi Arrula, Yolanda Escobar Álvarez, Almudena García Castaño, Juan José Grau de Castro, Lara Iglesias Docampo, Julio Lambea Sorrosal, Pedro Pérez Segura, Antonio Rueda Domínguez, Francisco J. Campos Lucas, Irene Santamaría Rodríguez, Maria Bessa, Paula Gratal, Fernando Caballero Martínez, Diana Monge Martín, Cristina Antón Rodríguez, Rafael López.
Clinical and Translational Oncology – Octubre 2023

Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain
Vicente Guillem Porta, Servicio de Oncología Médica, Instituto Valenciano de Oncología, Valencia, Spain.
Carlos Camps, Miguel Ángel Climent Durán, Enrique Gallardo, Aránzazu González del Alba, Martín Lázaro-Quintela, María José Méndez Vidal, Álvaro Pinto Marín, Javier Puente, Cristina Antón-Rodríguez, Fernando Caballero-Martínez, Francisco J. Campos-Lucas, Ilse Lugo, Álvaro Rogado, Ignacio Durán.
Clinical and Translational Oncology – Septiembre 2021

Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications
Carlos Camps, Servicio de Oncología Médica, Hospital General de Valencia, Valencia, Spain.
Rafael López, Antonio Antón, Enrique Aranda, Alfredo Carrato, Juan Jesús Cruz, Alberto Jacobo Cunquero-Tomás, Eduardo Díaz-Rubio, Margarita Feyjóo, Jesús García-Foncillas, Pere Gascón, Ilse Lugo, Álvaro Rogado, and Vicente Guillem.
JCO Oncology Practice – Febrero 2021

Patient Perspective on the Management of Cancer Pain in Spain
Antonio Antón-Torres, Fernando Caballero-Martínez, Francisco J Campos, Margarita Feyjoo, Alfonso Gomez de Liaño, Diana Monge, and Carlos Camps.
Journal of Patient Experience – Diciembre 2020

Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts
Antonio Antón Torres, Juan Jesús Cruz-Hernández, Alfredo Carrato, Manuel Constenla, Eduardo Díaz-Rubio, Margarita Feyjoo Saus, Jesus Garcia-Foncillas, Pere Gascón, Vicente Guillem.
Journal of Pain Research – Julio 2019

Breakthrough cancer pain: review and calls to action to improve its management
C. Camps Herrero, Servicio de Oncología Médica, Hospital General de Valencia, Valencia, Spain.
N. Batista, N. Díaz Fernández, Y. Escobar Álvarez, A. Gonzalo Gómez, D. Isla Casado, A. Salud, J. Terrasa Pons , V. Guillem Porta.
Clinical and Translational Oncology – Enero 2020

Development of a Multicriteria Decision Analysis Framework for Evaluating and Positioning Oncologic Treatments in Clinical Practice
Carlos Camps, Servicio de Oncología Médica, Hospital General de Valencia, Valencia, Spain.
Xavier Badia, Rosario García-Campelo, Jesus García-Foncillas, Rafael Lopez, Bartomeu Massuti, Mariano Provencio, Ramon Salazar, Juan Virizuela, Vicente Guillem.
Clinical and Translational Oncology – Enero 2020

Clinical practice evaluation of opioids induced constipation management in patients with cancer: The EIO-50 project
Francisco Javier Salvador Bofill, Margarita Feyjoo, Antonio Antón, Enrique Aranda, Carlos Camps, Alfredo Carrato, Manuel Constenla, Juan Jesús Cruz-Hernández, Eduardo Díaz-Rubio, Jesús GarcíaFoncillas, Pere Gascón, Rafael López, Begoña Soler* and Yolanda Escobar.
Open Journal of Pain Medicine – Diciembre 2019

Analysis of care for cancer patients with opioid-induced constipation in clinical practice: EIO-PRAXIS Project
Enrique Aranda, Medical Oncology Department, Hospital Reina Sofía, Córdoba, Spain.
Jesús García-Foncillas, Antonio Antón, Carlos Camps, Alfredo Carrato, Manuel Constenla, Juan J Cruz-Hernández, Eduardo Díaz-Rubio, Pere Gascón, Vicente Guillem, Rafael López, Margarita Feyjoo, Begoña Soler*, Javier Puente.
Open Journal of Pain Medicine – Diciembre 2019

Delphi Consensus on the Follow-up of Cancer Patients with Breakthrough Pain Under Opioid Treatment
José Luis Larriba González, Servicio de Oncología Médica, Hospital Clínico San Carlos Departamento de Medicina, Madrid, Spain.
Diego Cayuela López, Ovidio Fernández Calvo, Salvador Garcerá Juan, Raquel Molina Villaverde, Juan José Reina Zoilo, Vicente Guillém, Carlos Camps, Margarita Feyjóo.
Journal of Clinical Oncology – Agosto 2019

Recommendations for the management of cutaneous squamous cell carcinoma: a systematic multidisciplinary Delphi consensus approach
Javier Cañueto, Vanessa Jerviz Guía, Ana María López López, Josep Oriol Bermejo Segú, Almudena García Castaño, Susana Puig Sardá, Onofre Sanmartín Jiménez, Ainara Soria Rivas, Paula Gratal, María Teresa Pardo, Álvaro Rogado, Alfonso Berrocal Jaime.
Clinical and Translational Oncology – Diciembre 2024

Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)
J.J. Reina Zoilo, D. Monge Martín, F. Caballero Martínez, V. Guillem Porta, E. Aranda Aguilar, A. Carrato Mena, E. Díaz Rubio García, J. García Foncillas López, M. Feijóo Saus, R. López López.
Clinical and Translational Oncology – Julio 2018

Management of hyperbilirubinaemia in pancreatic cancer patients
A. Carrato Adeva, I. Ale´s, S. Prados, M. Valladares, T. Macarulla, A. Muñoz, M. Hidalgo.
European Journal of Cancer – Marzo 2018

Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study
C. Camps Herrero, P. Khosravi-Shahi, V. Guillem Porta, A. Carrato Mena, J. Garcia-Foncillas, J. J. Cruz Hernández, P. Gascón Vilaplana, A. Antón Torres, E. Diaz-Rubio, M. Feyjoo Saus, E. Aranda Aguilar.
Clinical and translational Oncology – Septiembre 2017

Adjuvant treatment for pancreatic ductal carcinoma
Teresa Macarulla Mercadé, Departamento de Oncología Médica, Hospital Vall d’Hebrón, Barcelona, Spain.
T. Fernández, M. E. Gallardo, O. Hernando, A. M. López, M. Hidalgo.
Clinical and translational Oncology – June 2017

Biomarkers in pancreatic ductal adenocarcinoma
Javier Gallego, Departamento de Oncología Médica, Hospital Universitario de Elche, Alicante, Spain.
C. López, R. Pazo-Cid, F. López-Ríos, A. Carrato.
Clinical and translational Oncology – June 2017

Surgery for pancreatic ductal adenocarcinoma
L. Díez, E. Martín Pérez, J. C. Plaza, A. Sanjuanbenito, A. Carrato
Clinical and translational Oncology – June 2017

Pancreatic ductal adenocarcinoma: metastatic disease
J. Adeva, J. Martínez-Galán, J. J. Reina, M. Hidalgo.
Clinical and translational Oncology – June 2017

Supportive care in pancreatic ductal adenocarcinoma
Berta Laquente Saez, Departamento de Oncología Médica, Instituto Catalán de Oncología, L’Hospitalet de Llobregat, Barcelona, Spain.
A. Calsina-Berna, A. Carmona-Bayonas, P. Jiménez-Fonseca, I. Peiró, A. Carrato.
Clinical and translational Oncology – June 2017

Diagnosis and staging of pancreatic ductal adenocarcinoma
Carmen Guillén Ponce, Departamento de Oncología Médica, Hospital Universitario Ramón y Cajal, Madrid, Spain.
J. Blázquez, I. González, E. de-Madaria, J. Montáns, A. Carrato.
Clinical and translational Oncology – June 2017

Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
Rafael Álvarez Gallego, Departamento de Oncología Médica, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Norte Sanchinarro, Madrid, Spain.
I. Alés, R. Díaz, B. G. de Paredes, M. Hidalgo.
Clinical and translational Oncology – June 2017

Management of unresectable, locally advanced pancreatic adenocarcinoma
Mercedes Salgado, Departamento de Oncología Médica, Complejo Hospitalario Universitario de Orense, Orense, Spain.
S. Arévalo, O. Hernando, A. Martínez, R. Yaya, M. Hidalgo .
Clinical and translational Oncology – June 2017
